Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04832087 · ClinicalTrials.gov registry record
Pediatric Teduglutide Registry
A clinical trial of Short Bowel Syndrome, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 142
- Enrollment target
- 1
- Study location
NCT04832087 is a study of Short Bowel Syndrome that has completed, run by Boston Children's Hospital. The registered enrollment target is 142 participants, below the 176-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04832087, a study of Short Bowel Syndrome, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
- 1
- Study location
Study Summary
Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.
Conditions Studied
Interventions
- DRUG Teduglutide
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2021-05-18 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04832087
The ClinicalTrials.gov registry entry for NCT04832087 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (19% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Short Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Teduglutide is the first listed.
NCT04832087 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04832087 about?
NCT04832087 is a clinical study titled "Pediatric Teduglutide Registry". Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.
What is the current status of trial NCT04832087?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2021-05-18. Estimated completion is 2023-08-31.
What conditions does trial NCT04832087 study?
This clinical trial studies the following conditions: Short Bowel Syndrome.
What interventions are being tested in trial NCT04832087?
The interventions under investigation include: Teduglutide (DRUG).
Who is sponsoring clinical trial NCT04832087?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04832087 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Short Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
RECRUITING · NA
-
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
RECRUITING · Early Phase 1
-
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
RECRUITING · Phase 2
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
RECRUITING · NA
-
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
RECRUITING · Phase 3
-
Registry for Participants With Short Bowel Syndrome
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.